Bristol Myers Squibb, Boehringer Ingelheim and Roche most mature pharmas on social media (but still room for improvement)

"Bristol Myers Squibb, Boehringer Ingelheim and Roche are the most mature pharmas on social media, though there are still areas in which the companies can do better.

That’s according to a new report by Ogilvy Health. For the first time since 2020, the healthcare agency giant has ranked and reported on how well, or not, pharmas are using social media.

For the report, Social Check-Up 2023, the Ogilvy team assessed the social media use of 10 pharma companies based on their Facebook, Instagram, Twitter, YouTube and LinkedIn streams between the summer of 2021 and the summer of 2022.

Those 10 pharmas: AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Gilead Sciences, GSK, Merck & Co., Novartis, Pfizer, UCB and Roche, were ranked and scored out of a possible perfect score of 30. The report said that its ranking is “not about improvements in the number of followers, but about what companies have done to nurture and engage with communities.”..." Lire la suite